Gene: GNAZ
Official Full Name: G protein subunit alpha zprovided by HGNC
Gene Summary: The protein encoded by this gene is a member of a G protein subfamily that mediates signal transduction in pertussis toxin-insensitive systms. This encoded protein may play a role in maintaining the ionic balance of perilymphatic and endolymphatic cochlear fluids. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37605 | GNAZ Knockout cell line (HeLa) | Human | GNAZ | 1:3~1:6 | Negative | Online Inquiry |
KO37606 | GNAZ Knockout cell line (HCT 116) | Human | GNAZ | 1:2~1:4 | Negative | Online Inquiry |
KO37607 | GNAZ Knockout cell line (HEK293) | Human | GNAZ | 1:3~1:6 | Negative | Online Inquiry |
KO37608 | GNAZ Knockout cell line (A549) | Human | GNAZ | 1:3~1:4 | Negative | Online Inquiry |
GNAZ Gene Knockout Cell Lines are advanced, engineered cellular models that have been specifically developed to facilitate the study of gene function by precisely knocking out target genes. This innovative platform utilizes cutting-edge CRISPR/Cas9 technology to create stable cell lines devoid of specific genomic sequences, enabling researchers to investigate the biological consequences of gene loss in a controlled environment. By providing a tool to dissect gene roles, the GNAZ cell lines empower scientists to uncover molecular pathways and unravel complex disease mechanisms.
The primary function of these knockout cell lines lies in their ability to facilitate functional genomics research, with applications spanning drug discovery, cancer research, and metabolic studies. The unique mechanism of action relies on the precision of the CRISPR/Cas9 system, which allows for high specificity in gene editing, minimizing off-target effects that can confound experimental outcomes. Additionally, GNAZ Gene Knockout Cell Lines can be utilized in the testing of therapeutic targets, providing a reliable preclinical model to validate the efficacy of novel compounds.
The scientific significance of utilizing GNAZ cell lines in both research and clinical contexts is profound. They serve as essential resources for understanding gene function and disease pathology, with potential translational applications aimed at improving patient outcomes. Compared to alternative gene-editing methods, such as traditional knockout models and RNA interference, GNAZ cell lines offer enhanced efficiency, reproducibility, and longer-term stability, reducing the need for continual re-optimization of gene-editing protocols.
For researchers and clinicians, the value of GNAZ Gene Knockout Cell Lines extends beyond their functional capabilities; they represent a significant advancement in creating robust, high-fidelity models that reflect true biological systems, ultimately accelerating the pace of discovery. With a commitment to supporting scientific innovation, our company leverages its extensive expertise in molecular biology and genetic engineering to deliver exemplary products that meet the demanding needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.